As­traZeneca push­es for­ward with Tagris­so com­bos, tout­ing PhII da­ta with Hutchmed drug

In a new da­ta read­out ex­plor­ing a po­ten­tial Tagris­so com­bi­na­tion ther­a­py, As­traZeneca re­vealed Mon­day morn­ing that it’s all about the MET.

As­traZeneca re­port­ed that 32 …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.